title: Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol.
abstract: The effect of GABAergic drugs on the motor-impairing effects of ethanol, barbital, and lorazepam were studied in the ethanol-sensitive ANT (Alcohol Nontolerant) and ethanol-insensitive AT (Alcohol Tolerant) rat lines, selected for differential ethanol-induced motor impairment on the tilting plane. The basic population from which these rat lines were derived, the mixed (M) line, was also included in the study. The ANT rats were more sensitive to the intoxicating effects of ethanol, barbital, and lorazepam than the AT and M rats at the dose ranges tested. Picrotoxin antagonized motor impairment from all three drugs. Flumazenil (Ro 15-1788) antagonized only the effects of lorazepam, and isoniazid did not modify motor impairment induced by any of the three drugs. These results confirm that the selection of AT and ANT lines has not been specific to ethanol, and that it has increased sensitivity to ethanol, barbital, and lorazepam in the ANT rats rather than decreasing it in the AT rats relative to the M rats. The finding that picrotoxin counteracted motor impairment from ethanol, barbital, and lorazepam support the view that the GABAA receptor complex is important in mediating the intoxicating effects of these drugs. These results also suggest that the genetically-determined difference in sensitivity to ethanol between the rat lines involves GABAergic mechanisms, but it remains to be determined whether any part of the GABAA receptor itself has been affected by the selection program.
authors.affiliation: Research Laboratories, Alko Ltd., Helsinki, Finland.
authors.forename: K
authors.initials: K
authors.lastname: Hellevuo
authors.forename: K
authors.initials: K
authors.lastname: Kiianmaa
authors.forename: E R
authors.initials: ER
authors.lastname: Korpi
mesh_terms: D000818:Animals; D001462:Barbital / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D001463:Barbiturates / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D005260:Female; D005442:Flumazenil / Q000494:pharmacology; D018756:GABA Antagonists; D007538:Isoniazid / Q000494:pharmacology; D008140:Lorazepam / Q000008:administration & dosage / Q000494:pharmacology*; D010852:Picrotoxin / Q000494:pharmacology; D011597:Psychomotor Performance / Q000187:drug effects*; D051381:Rats; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology*
chemical_list: D001462:Barbital; D001463:Barbiturates; D000431:Ethanol; D005442:Flumazenil; D018756:GABA Antagonists; D007538:Isoniazid; D008140:Lorazepam; D010852:Picrotoxin; D005680:gamma-Aminobutyric Acid